A randomized, multicenter trial assessing the effects of rapastinel compared to ketamine, alprazolam, and placebo on simulated driving performance
Abstract N‐methyl‐D‐aspartate ionotropic glutamatergic receptor (NMDAR) modulators, including rapastinel and ketamine, elicit rapid and sustained antidepressant responses in patients with treatment‐resistant major depressive disorder. This phase I, randomized, multicenter, placebo‐controlled, five‐p...
Saved in:
Main Authors: | Shengfang Su (Author), Gary Kay (Author), Thomas Hochadel (Author), Jonathan Rojo (Author), J. Christopher Stein (Author), Ramesh Boinpally (Author), Antonia Periclou (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Propofol versus placebo (with rescue with ketamine) before less invasive surfactant administration: study protocol for a multicenter, double-blind, placebo controlled trial (PROLISA)
by: Marie Chevallier, et al.
Published: (2020) -
Effects of CYP3A4 and P-glycoprotein inhibition or induction on the pharmacokinetics of ubrogepant in healthy adults: Two phase 1, open-label, fixed-sequence, single-center, crossover trials
by: Abhijeet Jakate, et al.
Published: (2021) -
Effects of Alprazolam on the Follicular Development of Rat Ovaries
by: Mohammad Shadkhast, et al.
Published: (2018) -
Pregnancy and Neonatal Outcomes After Exposure to Alprazolam in Pregnancy
by: Hyunji Lee, et al.
Published: (2022) -
Preparation of Alprazolam Extended- Release Tablets and In vitro Characterization
by: Mohammad Reza Avadi, et al.
Published: (2017)